Can low-dose aspirin really help treat many human diseases?

in this paper, the small compilation of a number of important research results, to explain whether low-dose aspirin can really help to treat a variety of human diseases? Share it with everyone!
Picture Source: CC0 Public Domain .
BJCP: Low-dose aspirin may reduce the risk of cardiovascular disease but increase the risk of gastrointestinal and intracranial bleeding doi: 10.1111/bcp.14310 recently published in the international journal British Journal of Clinical Medicines In the study " Effect of low-dose aspirin on health outcomes: An umbrella review of the system reviews and meta-analyses", scientists from institutions such as the University of Anglia Ruskin found that low doses of aspirin may significantly reduce the risk of cardiovascular disease, but increase the risk of bleeding.the researchers did not know the overall balance between the risks and benefits of taking aspirin, and for that reason they collected all relevant observational studies and data related to randomized controlled trials. In people without cardiovascular disease, the use of low-dose aspirin was associated with a 17 percent reduction in cardiovascular events, including non-fatal heart attacks, non-fatal
stroke
or cardiovascular-related deaths, while low-dose aspirin was directly related to a 47 percent increased risk of gastrointestinal bleeding and a 34 percent increase in intracranial bleeding risk, the researchers said.2:
NEJM Hammer! 50,000 people who have been exposed to low-dose aspirin for 10 years have found that low-dose aspirin reduces the risk of liver cancer doi: 10.1056/NEJMoa 1912035 a recent study published in the international journal The New England Journal of Medicine of Medicine, scientists from institutions such as the Caroline Institute in Sweden, found that people who took low-dose aspirin for a long time in adults with high-risk chronic toxic hepatitis were less likely to develop

liver cancer or die of liver-related diseases.researchers say that in the United States and Europe, liver and liver disease mortality rates are rising at an alarming rate, but there are no definitive treatments to prevent the development of liver cancer or reduce the risk of liver-related deaths. "For analysis, the researchers examined the registration information of 50,275 adults from Sweden with chronic toxic hepatitis. Chronic toxic hepatitis is a liver infection caused by the hepatitis B or C virus and is the most common risk factor for liver cancer. Over a 10-year period, 4.0% of patients taking small doses of aspirin (less than 163 mg per day) had liver cancer, and 8.3% of patients who did not take aspirin had liver cancer. People who took aspirin had a 31 percent lower risk of
liver cancer
.3)
the magic medicine again! Low-dose aspirin may be effective in treating head and neck cancer and lung cancer!News Read:
Can aspirin tackle stackle some cancers? , at the
of the American
Cancerconference in Chicago, scientists from the Roswell Park Comprehensive Cancer Research Center and other institutions found that low-dose aspirin may improve survival rates in patients with head and neck and lung cancer. In the first study, the researchers reviewed data from 460 head and neck squamous cell carcinoma (HNSCC) or early non-small cell lung cancer (NSCLC), and found that ingesting nonsteroidal anti-inflammatory drugs, such as low-dose aspirin, together with standard radiotherapy or chemotherapy, could increase the survival rate of these cancer patients by 8 percent.second study, researchers studied 164 nSCLC patients who received precision, high-dose radiotherapy, 57 percent of whom took aspirin for two years (compared to 48 percent of the other). 'We are particularly interested that these patients will survive longer, although anti-inflammatory drugs do not appear to have any effect on the effectiveness of cancer treatment,' said researcher Dr. Austin Iovoli.
Chest: Taking low-dose aspirin daily can alleviate chronic obstructive pulmonary disease! doi: 10.1016/j.chest.2018.11.028 Many Americans take low-dose aspirin daily to protect their hearts, but now a study suggests that aspirin also seems to prevent the onset of chronic obstructive pulmonary disease, in a study of COPD patients, and researchers found that aspirin is associated with a reduction in the moderate and severe risk of worsening COPD. "This study suggests that adding aspirin to existing treatment syllabees may improve the health of patients." Ashraf Fawzy, a lung and critical care researcher at Johns Hopkins University, said more research was needed to confirm it. The study was funded by NIH and Fawzy and colleagues looked at nearly 1,700 COPD patients. About 45 percent of patients reported taking low-dose aspirin (81 mg) regularly at the start of the study.researchers found that over the next three years, patients who took aspirin had fewer seizures, better quality of life and fewer breathing difficulties. COPD includes bronchitis and emphysema, two chronic lung diseases. Smoking is the main cause, but long-term exposure to toxic dust and chemicals is also a cause. Millions of Americans suffer from COPD, the third leading cause of lung disease-related deaths in the United States. There are currently treatments, but there is no cure, drugs usually include bronchodilators and anti-inflammatory drugs, and in more serious cases patients need to continue to take oxygen.
Sci Signal: God's medicine is re-tweeted! Low-dose aspirin may be effective against multiple sclerosis! : 10.1126/scisignal.aar8278a recent study published in the international journal Science Signaling, scientists from Lenox Hill Hospital in Manhattan found that low doses of aspirin may help effectively fight multiple sclerosis. Although the current study is being conducted in mouse organisms, the researchers believe the results of this study could be translated into human
clinical trials
later.Multiple Sclerosis (MS, multiple sclerosis) is a
autoimmune
disease in which the patient's own abnormal immune T cells attack and destroy the protective myelin that covers the surface of nerve cells. There are now more than 2.3 million people with multiple sclerosis worldwide, said researcher Asaff Harel, who has previously shown that aspirin can help improve weakness and other symptoms in people with multiple sclerosis.the study, researchers used aspirin to feed specially bred mice to mimic multiple sclerosis in humans, and found that low-dose aspirin appeared to be effective in suppressing symptoms in mice with multiple sclerosis, equivalent to 81 milligrams of infant stake, many of whom now take low-dose aspirin to prevent heart disease.
Picture Source: CC0 Public Domain . 6.
JAMA Oncol: Taking low-dose aspirin or reducing the risk of ovarian cancerdoi: 10.1001/jamaoncol.2018.4149 ovarian cancer is the fifth most common cause of cancer-related death in The United States. There is growing evidence that inflammation plays a role in the development of ovarian cancer, and it has been noted that local inflammation during ovulation may be a driver. Some analysts say aspirin reduces the risk of ovarian cancer by reducing inflammation. Although previous studies have tried to determine whether aspirin and other common anti-inflammatory drugs affect the risk of ovarian cancer, their findings are inconsistent. In a new study , researchers from Harvard's Zeng Zeng-hee School of Public Health, The Breggen Women's Hospital and the Moffett Cancer Research Center analyzed data from 205,498 women as part of the Nursing Health Study (Nurses' Health Study, NHS) and Nursing Health Research II. Of these women, 1,054 developed ovarian cancer. They studied the use of standard doses of aspirin, low-dose aspirin, non-steroidal anti-inflammatory drugs (non-steroidal anti-inflammatory drugs, NSAID), acetaminophen, and information on the number of tablets taken, frequency of use, time taken and duration of use, published in the journal JAMA Oncology.
JCR JIAIDSS: The god medicine is divine again! Low doses of aspirin may be effective in suppressing HIV infection and spread! : 10.1016/j.jconrel.2018.03.010 Scientists from the University of Manitoba in Canada have found that low-dose aspirin may be able to curb the spread of HIV, published in the international journal Research Journal of The International And THE International AIDS. HIV infection rates remain high in the population, especially among young African women, and in the study, researchers tested the effects of acetylsonic acid (ASA or aspirin) and other anti-inflammatory drugs on HIV-targeted cells in a joint study of women from low-risk HIV in Kenya. The preliminary findings, published in the Journal of the International AIDS Society, build on the role of inflammation in the spread of HIV. viruses require susceptibility to target cells in the human host body, active immune cells are often susceptible to HIV infection compared to other cells, and researchers know that inflammation often brings activated HIV-targeted cells into the female reproductive tract. The study, funded by the Canadian Institutes of Health and others, found that aspirin could be used as an effective anti-inflammatory drug to reduce the number of HIV-targeted cells in the female reproductive tract by 35 percent, and the study showed that the number of HIV-targeted cells in women who took aspirin decreased to the level of a Kenyan woman who was at high risk of HIV infection but had not been infected for years.
Ann Oncol: God's medicine! Taking aspirin may significantly reduce the risk of a variety of digestive tract cancers! doi: 10.1016/j.annonc.2020.02.012 aspirin is thought to be linked to a reduced risk of a variety of digestive cancers, such as pancreatic and
liver cancer
, a recent report, published in a recent report In a comprehensive analysis by scientists from the University of Milan and others in the international journal Annals of Oncology, the largest comprehensive analysis to date revealed a link between aspirin and gastrointestinal cancer, and the results showed that taking aspirin reduced the risk of gastrointestinal cancer by 22 to 38 percent. researchers say that sometimes aspirin also reduces the risk of bowel cancer, and a small analysis found that it also reduces the risk of esophageal and stomach cancer. For the study, researchers analyzed the results of 113 observational studies published through 2019, 45 of which were related to bowel cancer, including 156,000, and in addition to bowel cancer, the types of cancers surveyed included head and neck cancer, stomach cancer, esophagus cancer, and so on. Researcher Dr Cristina Bosetti said: 'We found that regular intake of aspirin, i.e. at least 1-2 per week, may significantly reduce the body's risk of all these cancers except head and neck cancer, in particular, the intake of aspirin is associated with a 27% reduction in the risk of bowel cancer (45 studies), and a 33% reduction in the risk of esophageal cancer (13 studies) A 39 percent reduction in cancer risk (10 studies) was associated with a 36 percent reduction in stomach cancer risk (14 studies), a 38 percent reduction in liver bile duct cancer (5 studies), and a 22 percent reduction in pancreatic cancer risk (15 studies), in which researchers did not find that aspirin intake was associated with a decrease in risk of head and neck cancer. 9:
The Dath: The Drug of God is again divine! Aspirin may be effective in suppressing the progression and recurrence of colorectal cancer! News Read
:
aspirin to curbs.